Healing

BPC-157

Also known as: Body Protection Compound-157, Pentadecapeptide BPC 157

Preclinical
Share:

Key Facts: BPC-157

Category
Healing
FDA Status
Not FDA Approved
Clinical Status
Preclinical - Extensive animal research, limited human trials
Administration
Subcutaneous injection near injury site, or systemic
Typical Dose
250-500 mcg twice daily
Frequency
1-2x daily
Evidence Level
Animal Studies
Duration
4-12 weeks in most research protocols
Also Known As
Body Protection Compound-157, Pentadecapeptide BPC 157

What to Expect

A synthetic peptide derived from a protein found in human gastric juice. Known for its remarkable tissue healing properties across multiple body systems.

Mechanism of Action

BPC-157 modulates the nitric oxide system, promotes angiogenesis (new blood vessel formation), and upregulates growth hormone receptors. It also interacts with the dopaminergic system and has been shown to accelerate tendon-to-bone healing by promoting collagen synthesis.

Research Summary

Extensive preclinical studies demonstrate efficacy in healing tendons, ligaments, muscles, and the GI tract. Animal studies show acceleration of wound healing, protection against NSAID-induced gut damage, and neuroprotective effects. Limited human clinical trials exist.

Clinical Status:Preclinical - Extensive animal research, limited human trials
Trial Progress:Preclinical
Pre
I
II
III
IV
FDA

Dosing Information

Animal Studies·Primarily animal/preclinical research

Note: Animal study doses may not translate directly to humans.

Typical Dosing

Community experience

Common Dose

250-500 mcg twice daily

Range

200-1,000 mcg per day total

Frequency

1-2x daily

Often injected subcutaneously near injury site for localized healing. Systemic administration also common. Many users split into morning and evening doses.

Research Dosing

Scientific studies

Doses observed in research studies

Duration

4-12 weeks in most research protocols

Administration

Subcutaneous injection near injury site, or systemic

Timing & Administration

Best Time to Take

Morning and evening (or near injury site timing)

1-2 times daily, consistent timing

Food Recommendation

With or without food

Why This Timing?

BPC-157 has systemic healing effects. Split dosing maintains stable levels. Can be timed around activity for injury healing.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

  • Generally well-tolerated in preclinical studies
  • Nausea
  • Dizziness
  • Injection site reactions
  • Fatigue
  • Headache
  • May trigger histamine release - use caution with MCAS or histamine sensitivity
  • Potential concern for tumor promotion (angiogenesis)
  • Limited long-term human safety data

References

Related Peptides

Peptides commonly compared with BPC-157 or used in similar applications.

Want updates on BPC-157 research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Educational Information Only

This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.